Sonova Raised Guidance. It Also Admitted Why.
A market-driven upgrade, a lost retail customer baked into H2, and a third year of deferred buybacks
SOON.SW · Earnings Call · 2026-11-12
The headline is genuinely good
Sonova's first half of FY2026/27 is, by any ordinary reading, a strong print. Group sales reached CHF 1.8 billion, up 7.5% in local currencies, with organic growth contributing 7 percentage points and M&A only 0.5. Core EBIT rose 22.9% to CHF 384 million and the core EBIT margin expanded 260 basis points to 20.9%. Hearing instruments grew 9% with core EBIT up 26% and margin at 22.0%. Wholesale grew 11% — double digits for twelve months and, by management's count, eleven consecutive quarters of year-on-year share gaining, taking tracked-market share from the mid-20s to the low 30s percent. Retail grew around 7%, more than 5% of it organic, accelerating in the second quarter. Operating free cash flow jumped to CHF 287 million from CHF 90 million, ROCE moved to 20.9% from 19.5%, and net debt to EBITDA sat at 1.1x. So the guide went up: sales growth of 6% to 8% (was 5% to 8%) and core EBIT growth of 10% to 13% (was 7% to 10%). “Against this background, we now expect consolidated sales growth of 6% to 8% compared with 5% to 8% previously. And we are also raising our core EBIT growth guidance to 10% to 13% compared with 7% to 10% previously.” — Elodie Carr-Cingari, Chief Financial Officer (CFO) · 2026-11-12 The interesting part is why.The upgrade belongs to the market, not to Sonova
Analysts pressed exactly this point, and the answer was refreshingly blunt. The bottom end of the sales range rose because the market assumption rose — from 2% to 4% up to 3% to 5% — not because share momentum surprised to the upside. Management then went further and pre-announced its own deceleration: the fiscal Q2 market was extraordinary, aided by a stocking effect in the channel that was explicitly not Sonova's. “About stocking effect, yes, there has been some stocking effects but not from Sonova and there was no specific push or creativity around optimizing the end of the quarter.” — Eric Bernard, Chief Executive Officer (CEO) · 2026-11-12 That is an unusually honest admission — it tells you H2 compares against a flattered base, and that the raised guidance is a market call dressed as a company call. Note the contrast with May, when the message was acceleration: “If you look at the very recent months, we're getting closer to 4%.” — Eric Bernard, Chief Executive Officer (CEO) · 2026-05-18 They got there faster than planned, and are now deliberately guiding below the achieved run rate. Fine. But it means the quality of the beat rests almost entirely on operating execution, not demand.The sentence that matters most
Buried in a Q&A answer about wholesale cadence is the single most consequential line on the call, and it is a structural revenue leak rather than a cyclical one.Translation: Amplifon is acquiring GN Hearing, and a large retail account Sonova supplies will migrate its sourcing to the combined group. Management pegged it as low single-digit percentage of sales (an analyst guessed as much and was not corrected), said it was already baked into guidance, and framed H2 as a period where Sonova still gains share despite it. That is a genuinely company-unique negative, and it is the kind of consolidation arithmetic that defines the current M&A cycle in hearing care. The contrast with six months ago is the story. In May, the same merger was treated as a non-event leaning positive: “So we don't expect a significant impact in the coming year. I would say also that this type of acquisition or merger could create opportunities.” — Eric Bernard, Chief Executive Officer (CEO) · 2026-05-18 It has now moved from theory to the P&L. Sonova is not losing a market, it is losing a customer — and customers are harder to replace than markets.I mentioned the fact that our Italian colleagues are likely to source from our Danish colleagues, so we will see a drop in revenues out of that.
Cochlear implants: a proof point with an American asterisk
CI sales fell 10%, with systems down 3% and upgrades down 27% — the mechanical consequence of a platform that had gone stale. Eric Bernard did not hide it: “So first half was obviously not satisfactory, minus 10%, but very much in line with our expectations.” — Eric Bernard, Chief Executive Officer (CEO) · 2026-11-12 Integro, launched in Europe mid-October and now in 18 countries, is the first real new platform in the franchise and shares Phonak's processing, microphone and connectivity technology — including the real-time AI pushed into the Roger On Sphere microphone. The problem is timing and geography. US launch remains subject to regulatory approval, and Bernard conceded it "may have an impact on our ability to generate positive growth for the full year." That is a softer line than a year ago, when the same question got a flat yes on positive CI growth for the fiscal year — and softer than May's framing of an H2 lift from the processor. The prior-call context makes the durability question sharper still:Integro fixes the cadence. It does not yet fix the calendar.Our latest innovation was brought to market in 2021. So we are slow to innovate versus our competition.